133 related articles for article (PubMed ID: 20580385)
21. Anti-apoptotic effect of morphine-induced delayed preconditioning on pulmonary artery endothelial cells with anoxia/reoxygenation injury.
Ding WG; Zhou HC; Cui XG; Li WZ; Guo YP; Zhang B; Liu W
Chin Med J (Engl); 2008 Jul; 121(14):1313-8. PubMed ID: 18713554
[TBL] [Abstract][Full Text] [Related]
22. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
Ogata T; Miyauchi T; Sakai S; Takanashi M; Irukayama-Tomobe Y; Yamaguchi I
J Am Coll Cardiol; 2004 Apr; 43(8):1481-8. PubMed ID: 15093887
[TBL] [Abstract][Full Text] [Related]
23. Renoprotective Effects of Fenofibrate via Modulation of LKB1/AMPK mRNA Expression and Endothelial Dysfunction in a Rat Model of Diabetic Nephropathy.
Al-Rasheed NM; Al-Rasheed NM; Attia HA; Al-Amin MA; Al-Ajmi HN; Hasan IH; Mohamad RA; Sinjilawi NA
Pharmacology; 2015; 95(5-6):229-39. PubMed ID: 25967095
[TBL] [Abstract][Full Text] [Related]
24. Fenofibrate induces apoptotic injury in cultured human hepatocytes by inhibiting phosphorylation of Akt.
Kubota T; Yano T; Fujisaki K; Itoh Y; Oishi R
Apoptosis; 2005 Mar; 10(2):349-58. PubMed ID: 15843896
[TBL] [Abstract][Full Text] [Related]
25. Total polyphenol of Anemarrhena asphodeloides ameliorates advanced glycation end products-induced endothelial dysfunction by regulation of AMP-Kinase.
Zhao Q; Sun Y; Ji Y; Xu L; Liu K; Liu B; Huang F
J Diabetes; 2014 Jul; 6(4):304-15. PubMed ID: 24245915
[TBL] [Abstract][Full Text] [Related]
26. The peroxisome proliferator-activated receptor pan-agonist bezafibrate suppresses microvascular inflammatory responses of retinal endothelial cells and vascular endothelial growth factor production in retinal pigmented epithelial cells.
Usui-Ouchi A; Ouchi Y; Ebihara N
Int Immunopharmacol; 2017 Nov; 52():70-76. PubMed ID: 28866026
[TBL] [Abstract][Full Text] [Related]
27. Fenofibrate lowers lipid accumulation in myotubes by modulating the PPARα/AMPK/FoxO1/ATGL pathway.
Chen WL; Chen YL; Chiang YM; Wang SG; Lee HM
Biochem Pharmacol; 2012 Aug; 84(4):522-31. PubMed ID: 22687626
[TBL] [Abstract][Full Text] [Related]
28. AMPK-dependent signaling modulates the suppression of invasion and migration by fenofibrate in CAL 27 oral cancer cells through NF-κB pathway.
Tsai SC; Tsai MH; Chiu CF; Lu CC; Kuo SC; Chang NW; Yang JS
Environ Toxicol; 2016 Jul; 31(7):866-76. PubMed ID: 25545733
[TBL] [Abstract][Full Text] [Related]
29. Fenofibrate improves vascular endothelial function and contractility in diabetic mice.
Xu N; Wang Q; Jiang S; Wang Q; Hu W; Zhou S; Zhao L; Xie L; Chen J; Wellstein A; Lai EY
Redox Biol; 2019 Jan; 20():87-97. PubMed ID: 30296701
[TBL] [Abstract][Full Text] [Related]
30. Fenofibrate decreases asymmetric dimethylarginine level in cultured endothelial cells by inhibiting NF-kappaB activity.
Yang TL; Chen MF; Luo BL; Xie QY; Jiang JL; Li YJ
Naunyn Schmiedebergs Arch Pharmacol; 2005 May; 371(5):401-7. PubMed ID: 15915325
[TBL] [Abstract][Full Text] [Related]
31. Differential effects on lung cancer cell proliferation by agonists of glucocorticoid and PPARα receptors.
Liang H; Kowalczyk P; Junco JJ; Klug-De Santiago HL; Malik G; Wei SJ; Slaga TJ
Mol Carcinog; 2014 Sep; 53(9):753-63. PubMed ID: 23625588
[TBL] [Abstract][Full Text] [Related]
32. A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells.
Hattori Y; Jojima T; Tomizawa A; Satoh H; Hattori S; Kasai K; Hayashi T
Diabetologia; 2010 Oct; 53(10):2256-63. PubMed ID: 20593161
[TBL] [Abstract][Full Text] [Related]
33. Metformin activation of AMPK suppresses AGE-induced inflammatory response in hNSCs.
Chung MM; Nicol CJ; Cheng YC; Lin KH; Chen YL; Pei D; Lin CH; Shih YN; Yen CH; Chen SJ; Huang RN; Chiang MC
Exp Cell Res; 2017 Mar; 352(1):75-83. PubMed ID: 28159472
[TBL] [Abstract][Full Text] [Related]
34. The peroxisome proliferator-activated receptor α agonist fenofibrate decreases airway reactivity to methacholine and increases endothelial nitric oxide synthase phosphorylation in mouse lung.
Becker J; Delayre-Orthez C; Frossard N; Pons F
Fundam Clin Pharmacol; 2012 Jun; 26(3):340-6. PubMed ID: 21392098
[TBL] [Abstract][Full Text] [Related]
35. Calcitriol counteracts endothelial cell pro-inflammatory processes in a chronic kidney disease-like environment.
Talmor-Barkan Y; Bernheim J; Green J; Benchetrit S; Rashid G
J Steroid Biochem Mol Biol; 2011 Mar; 124(1-2):19-24. PubMed ID: 21236342
[TBL] [Abstract][Full Text] [Related]
36. Delayed treatment with fenofibrate protects against high-fat diet-induced kidney injury in mice: the possible role of AMPK autophagy.
Sohn M; Kim K; Uddin MJ; Lee G; Hwang I; Kang H; Kim H; Lee JH; Ha H
Am J Physiol Renal Physiol; 2017 Feb; 312(2):F323-F334. PubMed ID: 27465995
[TBL] [Abstract][Full Text] [Related]
37. Modified Si-Miao-San ameliorates pancreatic B cell dysfunction by inhibition of reactive oxygen species-associated inflammation through AMP-kinase activation.
Shang SW; Yang JL; Huang F; Liu K; Liu BL
Chin J Nat Med; 2014 May; 12(5):351-60. PubMed ID: 24856758
[TBL] [Abstract][Full Text] [Related]
38. PPARα agonist, fenofibrate, ameliorates age-related renal injury.
Kim EN; Lim JH; Kim MY; Kim HW; Park CW; Chang YS; Choi BS
Exp Gerontol; 2016 Aug; 81():42-50. PubMed ID: 27130813
[TBL] [Abstract][Full Text] [Related]
39. Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-α partly via preventing p65-NFκB binding to NFATc4.
Zou J; Le K; Xu S; Chen J; Liu Z; Chao X; Geng B; Luo J; Zeng S; Ye J; Liu P
Mol Cell Endocrinol; 2013 May; 370(1-2):103-12. PubMed ID: 23518069
[TBL] [Abstract][Full Text] [Related]
40. Effect of Fenofibrate on the Expression of Inflammatory Mediators in a Diabetic Rat Model.
Yeh PT; Wang LC; Chang SW; Yang WS; Yang CM; Yang CH
Curr Eye Res; 2019 Oct; 44(10):1121-1132. PubMed ID: 31109206
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
